Ítem
Acceso Abierto

Factores asociados a uso inapropiado de opioides en dolor crónico no oncológico en una población de Bogotá

Mostrar el registro sencillo de la publicación
dc.contributorAguilera, Paula
dc.contributorPedraza Flechas, Ana Maria
dc.contributor.advisorDaza Vergara, José Alejandro
dc.contributor.advisorIsaza Narváez, Ana Milena
dc.creatorRondón Lizarazo, Maria Paula
dc.creatorSalazar Rodríguez, Diana Maritza
dc.creator.degreeEspecialista en Medicina del Dolor y Cuidado Paliativospa
dc.creator.degreetypeFull timespa
dc.date.accessioned2019-08-13T21:44:15Z
dc.date.available2019-08-13T21:44:15Z
dc.date.created2019-07-25
dc.date.issued2019
dc.descriptionObjetivo: El dolor crónico no oncológico (DCNO) constituye un problema de salud pública. Su manejo con opioides ha crecido exponencialmente y consigo el uso inapropiado de opioides prescritos (UIOP). El objetivo primario fue identificar la prevalencia del riesgo de UIOP y los factores relacionados con este en un Hospital de IV nivel en Bogotá. Metodología: Se incluyeron 260 sujetos mayores de edad, en manejo con opioides por DCNO, en un periodo entre enero y abril de 2019. Se evaluó el riesgo del UIOP utilizando la escala SOAPP-®R (>18 puntos) y para detectar el abuso de otras sustancias la escala ASSIST. Luego se aplicó un cuestionario propio con variables que pudieran influir en el resultado de la escala SOAPP-®R. Mediante análisis estadístico descriptivo se identificó la prevalencia del riesgo. Para identificar factores relacionados al riesgo se usó una regresión logística ordinal. Resultados: La prevalencia encontrada fue de 56,5% y como factores relacionados a mayor riesgo se encontraron: la edad entre 50 y 60 años (IC95% 3,53-22,06), opioides potentes (IC95% 1,42-4,7), tiempo de evolución del dolor (superior a 24 meses, p=0,038), dolor craneofacial (IC95% 1,81-24,65), dependencia funcional (IC95% 1,97-5,93) y depresión (IC95% 1,79-6,13). Conclusiones: El riesgo de UIOP en la población expuesta es alto y tiene diversos factores que aumentan la probabilidad de presentar conductas aberrantes con su uso, por lo cual es importante implementar escalas de riesgo como SOAPP-®R y diseñar estrategias preventivas que contribuyan a mitigar la aparición del evento en la población del Hospital y eventualmente del país.spa
dc.description.abstractObjective: Chronic non-cancer pain constitutes a worldwide public health problem. Sometimes it requires management with prescription opioids, which use can be associated with complications such as misuse/abuse of these drugs (POMA). The primary objective was to identify the risk prevalence and the risk factors associated with this kind of behaviors in the study population. Methodology: 260 subjects, who were assessed by pain services from Hospital Universitario due to CNCP, who fulfilled inclusion criteria, in a period of time between January and March 2019, were included. Subsequently, the SOAPP-®R, ASSIST scale and a questionnaire made by the PI were applied. With the results, by means of bivariate, multivariate and ordinal logistic linear regression analysis, the risk prevalence and the biopsychosocial factors that were associated with the relative risk of opioids misuse/abuse, were identified. Results: We found that the prevalence for the risk of POMA was 56.5% and as statistically significant factors associated with greater risk, we found: age between 50 and 60 years-old, strong opioids, the time of pain duration (more than 24 months), head and face pain/headache, functional dependence and depression. Conclusions: Acknowledging the risk prevalence and the factors associated with POMA for our Hospital population is very useful and important, given that it could help to generate/apply risk tools in the future, adjusted to the features of our population, in order to assess this risk and thus take further actions that reduce the risk of occurrence of these events and bring benefit to the patients.spa
dc.description.embargo2021-08-14 01:01:01: Script de automatizacion de embargos. info:eu-repo/date/embargoEnd/2021-08-13
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_20102
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/20102
dc.language.isospaspa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentEscuela de Medicina y Ciencias de la Saludspa
dc.publisher.programEspecialización en Medicina del Dolor y Cuidado Paliativospa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombiaspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.source.bibliographicCitation1. Campbella, G., et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2015; Feb;156(2):231-42.spa
dc.source.bibliographicCitation2. Sehgal, N., Manchikanti, L., Smith, HS. Prescription Opioid Abuse in Chronic Pain: A Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse. Pain Physician. 2012 Jul;15(3 Suppl):ES67-92.spa
dc.source.bibliographicCitation3. Kaye, A.D. et al. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain Physician 2017; 20: S93-S109.spa
dc.source.bibliographicCitation4. Airam, A., Hammam A., Gururau S. Prevention of Opioid Abuse in Chronic Non-Cancer Pain: An Algorithmic, Evidence Based Approach. Pain Physician 2012; 15:ES177-ES189.spa
dc.source.bibliographicCitation5. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine. 2005;30:1075–1081.spa
dc.source.bibliographicCitation6. Voon P, Karamouzian M, Kerr T.Chronic pain and opioid misuse: a review of reviews. Substance Abuse Treatment, Prevention, and Policy 2017; 12:36.spa
dc.source.bibliographicCitation7. Palmer R.E, et al. The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes. Pain 2015; Jul;156(7):1208-14.spa
dc.source.bibliographicCitation8. Boyd, C., et al. Motives for Medical Misuse of Prescription Opioids Among Adolescent. J Pain. 2013 Oct; 14(10): 1208–1216.spa
dc.source.bibliographicCitation9. Carter, J., et al. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: Mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014 May 1;138:202-8.spa
dc.source.bibliographicCitation10. Dart, RC., et al. Trends in abuse and misuse of prescription opioids among older. Drug Alcohol Depend. 2015 Apr 1;149:117-21.spa
dc.source.bibliographicCitation11. Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012 Jun;72(6):443-51.spa
dc.source.bibliographicCitation12. Volkow, N., McLellan, A.T. Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies. Engl J Med 2016; 374:1253-1263.spa
dc.source.bibliographicCitation13. Guerrero A, Gómez P. VIII Estudio Nacional de Dolor 2014 - Prevalencia del dolor crónico en Colombia. Asociación Colombiana para el Estudio de Dolor. 2016.spa
dc.source.bibliographicCitation14. Just J. et al. Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study. BMC Family Practice 2018; 19:92.spa
dc.source.bibliographicCitation15. Gobierno Nacional de la República de Colombia. Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia. 2013.spa
dc.source.bibliographicCitation16. Pagé, M.G., et al. Risk of Opioid Abuse and Biopsychosocial Characteristics Associated With This Risk Among Chronic Pain Patients Attending a Multidisciplinary Pain Treatment Facility. Clin J Pain. 2016 Oct;32(10):859-69.spa
dc.source.bibliographicCitation17. Amsterdam J.V, Van den Brink W. The Misuse of Prescription Opioids: A Threat for Europe?. Current Drug Abuse Reviews 2015; 8: 3-14.spa
dc.source.bibliographicCitation18. Ballantyne, JC. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg 2017;125:1769–78.spa
dc.source.bibliographicCitation19. Pergolizzi Jr, J. V., Gharibo, C., Passik, S., Labhsetwar, S., Taylor Jr, R., Pergolizzi, J. S., & Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. Journal of psychosomatic research 2012; 72(6): 443-451.spa
dc.source.bibliographicCitation20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub, 2013.spa
dc.source.bibliographicCitation21. American College of Preventive Medicine. Use, Abuse, Misuse, and disposal of prescription pain medication time tool: A Resource from the American College of Preventive Medicine. 2011. Tomado de: http://www.acpm.org/?UseAbuseRxClinRefspa
dc.source.bibliographicCitation22. Ballantyne, J.C, LaForge, K,S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129: 235–255.spa
dc.source.bibliographicCitation23. Johnson S, North R. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992; 12: 483–8.spa
dc.source.bibliographicCitation24. Bonci A, Williams J. Increased probability of GABA release during withdrawal from morphine. J Neurosci. 1997; 17: 796–803.spa
dc.source.bibliographicCitation25. Cami, J., Farre, M. Drug addiction. N Engl J Med 2003; 349: 975–86.spa
dc.source.bibliographicCitation26. Hyman S, Malenka R. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001; 2: 695–703.spa
dc.source.bibliographicCitation27. Robinson T, Berridge K. Addiction. Annu Rev Psychol 2003; 54: 25–53.spa
dc.source.bibliographicCitation28. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:276–86.spa
dc.source.bibliographicCitation29. Vowles K.E, McEntee M.L, Julnes P.S, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:569-76.spa
dc.source.bibliographicCitation30. Webster, L. R. Risk factors for opioid-use disorder and overdose. Anesthesia & Analgesia 2017; 125(5): 1741-1748.spa
dc.source.bibliographicCitation31. McCabe SE, West BT, Boyd CJ. Motives for medical misuse of prescription opioids among adolescents. The Journal of Pain 2013:14: 1208-1216spa
dc.source.bibliographicCitation32. Kirson, N. Y., Scarpati, L. M., Enloe, C. J., Dincer, A. P., Birnbaum, H. G., & Mayne, T. J. The economic burden of opioid abuse: updated findings. Journal of managed care & specialty pharmacy 2017; 23(4): 427-445.spa
dc.source.bibliographicCitation33. Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US Commercial Health Plan Claims Database. Pain Med. 2017 Mar 6 [Epub ahead of print].spa
dc.source.bibliographicCitation34. Klimas J, et al. Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain. JAMA Network Open 2019; 2(5): e193365.spa
dc.source.bibliographicCitation35. Grau, LE. Chronic pain, Addiction severity, and misuse of opioids in Cumberland County. Addict Behav. 2012 Mar;37(3):346-9.spa
dc.source.bibliographicCitation36. Pletcher M.J, Kertesz S.G, Kohn M.A, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. Jama. 2008; 299: 70-78.spa
dc.source.bibliographicCitation37. Lanier W.A., Johnson E.M., Rolfs R.T., Friedrichs M.D., Grey T.C. Risk Factors for Prescription Opioid-Related Death, Utah, 2008–2009. Pain Medicine 2012;13: 1580-1589.spa
dc.source.bibliographicCitation38. Akbik H, et al. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006; 32(3):287-293.spa
dc.source.bibliographicCitation39. Organización Mundial de la Salud . La prueba de detección de consumo de alcohol, tabaco y sustancias (ASSIST) - Manual para uso en la atención primaria, 2011.spa
dc.source.bibliographicCitation40. Kanouse, A. B., & Compton, P. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response. Journal of pain & palliative care pharmacotherapy 2015; 29(2): 102-114.spa
dc.source.bibliographicCitation41. Lee, Y. H., Brown, D. L., & Chen, H. Y. Current Impact and Application of Abuse-Deterrent Opioid Formulations in Clinical Practice 2017; 20(7):E1003-E1023.spa
dc.source.bibliographicCitation1. Campbella, G., et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2015; Feb;156(2):231-42.spa
dc.source.bibliographicCitation2. Sehgal, N., Manchikanti, L., Smith, HS. Prescription Opioid Abuse in Chronic Pain: A Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse. Pain Physician. 2012 Jul;15(3 Suppl):ES67-92.spa
dc.source.bibliographicCitation3. Kaye, A.D. et al. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain Physician 2017; 20: S93-S109.spa
dc.source.bibliographicCitation4. Airam, A., Hammam A., Gururau S. Prevention of Opioid Abuse in Chronic Non-Cancer Pain: An Algorithmic, Evidence Based Approach. Pain Physician 2012; 15:ES177-ES189.spa
dc.source.bibliographicCitation5. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine. 2005;30:1075–1081.spa
dc.source.bibliographicCitation6. Voon P, Karamouzian M, Kerr T.Chronic pain and opioid misuse: a review of reviews. Substance Abuse Treatment, Prevention, and Policy 2017; 12:36.spa
dc.source.bibliographicCitation7. Palmer R.E, et al. The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes. Pain 2015; Jul;156(7):1208-14.spa
dc.source.bibliographicCitation8. Boyd, C., et al. Motives for Medical Misuse of Prescription Opioids Among Adolescent. J Pain. 2013 Oct; 14(10): 1208–1216.spa
dc.source.bibliographicCitation9. Carter, J., et al. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: Mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014 May 1;138:202-8.spa
dc.source.bibliographicCitation10. Dart, RC., et al. Trends in abuse and misuse of prescription opioids among older. Drug Alcohol Depend. 2015 Apr 1;149:117-21.spa
dc.source.bibliographicCitation11. Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012 Jun;72(6):443-51.spa
dc.source.bibliographicCitation12. Volkow, N., McLellan, A.T. Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies. Engl J Med 2016; 374:1253-1263.spa
dc.source.bibliographicCitation13. Guerrero A, Gómez P. VIII Estudio Nacional de Dolor 2014 - Prevalencia del dolor crónico en Colombia. Asociación Colombiana para el Estudio de Dolor. 2016.spa
dc.source.bibliographicCitation14. Just J. et al. Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study. BMC Family Practice 2018; 19:92.spa
dc.source.bibliographicCitation15. Gobierno Nacional de la República de Colombia. Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia. 2013.spa
dc.source.bibliographicCitation16. Pagé, M.G., et al. Risk of Opioid Abuse and Biopsychosocial Characteristics Associated With This Risk Among Chronic Pain Patients Attending a Multidisciplinary Pain Treatment Facility. Clin J Pain. 2016 Oct;32(10):859-69.spa
dc.source.bibliographicCitation17. Amsterdam J.V, Van den Brink W. The Misuse of Prescription Opioids: A Threat for Europe?. Current Drug Abuse Reviews 2015; 8: 3-14.spa
dc.source.bibliographicCitation18. Ballantyne, JC. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg 2017;125:1769–78.spa
dc.source.bibliographicCitation19. Pergolizzi Jr, J. V., Gharibo, C., Passik, S., Labhsetwar, S., Taylor Jr, R., Pergolizzi, J. S., & Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. Journal of psychosomatic research 2012; 72(6): 443-451.spa
dc.source.bibliographicCitation20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub, 2013.spa
dc.source.bibliographicCitation21. American College of Preventive Medicine. Use, Abuse, Misuse, and disposal of prescription pain medication time tool: A Resource from the American College of Preventive Medicine. 2011. Tomado de: http://www.acpm.org/?UseAbuseRxClinRefspa
dc.source.bibliographicCitation22. Ballantyne, J.C, LaForge, K,S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129: 235–255.spa
dc.source.bibliographicCitation23. Johnson S, North R. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992; 12: 483–8.spa
dc.source.bibliographicCitation24. Bonci A, Williams J. Increased probability of GABA release during withdrawal from morphine. J Neurosci. 1997; 17: 796–803.spa
dc.source.bibliographicCitation25. Cami, J., Farre, M. Drug addiction. N Engl J Med 2003; 349: 975–86.spa
dc.source.bibliographicCitation26. Hyman S, Malenka R. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001; 2: 695–703.spa
dc.source.bibliographicCitation27. Robinson T, Berridge K. Addiction. Annu Rev Psychol 2003; 54: 25–53.spa
dc.source.bibliographicCitation28. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:276–86.spa
dc.source.bibliographicCitation29. Vowles K.E, McEntee M.L, Julnes P.S, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:569-76.spa
dc.source.bibliographicCitation30. Webster, L. R. Risk factors for opioid-use disorder and overdose. Anesthesia & Analgesia 2017; 125(5): 1741-1748.spa
dc.source.bibliographicCitation31. McCabe SE, West BT, Boyd CJ. Motives for medical misuse of prescription opioids among adolescents. The Journal of Pain 2013:14: 1208-1216spa
dc.source.bibliographicCitation32. Kirson, N. Y., Scarpati, L. M., Enloe, C. J., Dincer, A. P., Birnbaum, H. G., & Mayne, T. J. The economic burden of opioid abuse: updated findings. Journal of managed care & specialty pharmacy 2017; 23(4): 427-445.spa
dc.source.bibliographicCitation33. Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US Commercial Health Plan Claims Database. Pain Med. 2017 Mar 6 [Epub ahead of print].spa
dc.source.bibliographicCitation34. Klimas J, et al. Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain. JAMA Network Open 2019; 2(5): e193365.spa
dc.source.bibliographicCitation35. Grau, LE. Chronic pain, Addiction severity, and misuse of opioids in Cumberland County. Addict Behav. 2012 Mar;37(3):346-9.spa
dc.source.bibliographicCitation36. Pletcher M.J, Kertesz S.G, Kohn M.A, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. Jama. 2008; 299: 70-78.spa
dc.source.bibliographicCitation37. Lanier W.A., Johnson E.M., Rolfs R.T., Friedrichs M.D., Grey T.C. Risk Factors for Prescription Opioid-Related Death, Utah, 2008–2009. Pain Medicine 2012;13: 1580-1589.spa
dc.source.bibliographicCitation38. Akbik H, et al. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006; 32(3):287-293.spa
dc.source.bibliographicCitation39. Organización Mundial de la Salud . La prueba de detección de consumo de alcohol, tabaco y sustancias (ASSIST) - Manual para uso en la atención primaria, 2011.spa
dc.source.bibliographicCitation40. Kanouse, A. B., & Compton, P. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response. Journal of pain & palliative care pharmacotherapy 2015; 29(2): 102-114.spa
dc.source.bibliographicCitation41. Lee, Y. H., Brown, D. L., & Chen, H. Y. Current Impact and Application of Abuse-Deterrent Opioid Formulations in Clinical Practice 2017; 20(7):E1003-E1023.spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subjectOpioidesspa
dc.subjectMedicamentos bajo prescripciónspa
dc.subjectTrastornos relacionados con opioidesspa
dc.subjectDolor crónicospa
dc.subjectDolor nociceptivospa
dc.subjectDolor crónico no oncológicospa
dc.subject.ddcEnfermedadesspa
dc.subject.keywordOpioidspa
dc.subject.keywordPrescription drugsspa
dc.subject.keywordOpioid-related disordersspa
dc.subject.keywordChronic painspa
dc.subject.keywordNociceptive painspa
dc.subject.keywordChronic non-cancer painspa
dc.subject.lembDolor crónicospa
dc.subject.lembOpiáceosspa
dc.subject.lembAnalgésicos opioidesspa
dc.titleFactores asociados a uso inapropiado de opioides en dolor crónico no oncológico en una población de Bogotáspa
dc.typemasterThesiseng
dc.type.documentTrabajo de gradospa
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de gradospa
local.department.reportEscuela de Medicina y Ciencias de la Saludspa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
Factores-asociados-a-uso-inapropiado-de-opioides-en-dolor-cronico-no-oncologico-en-una-poblacion-de-Bogota.pdf
Tamaño:
827.3 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Especialización en Medicina del Dolor y Cuidado Paliativo